Page last updated: 2024-11-09

4-fluorohippuric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-fluorohippuric acid: a urinary metabolite of fluorapacin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID699341
SCHEMBL ID1742166
MeSH IDM0536670

Synonyms (36)

Synonym
HMS1757J10
366-79-0
OPREA1_125280
2-[(4-fluorobenzoyl)amino]acetic acid
AKOS000114595
n-(4-fluorobenzoyl)glycine
STL140667
n-[(4-fluorophenyl)carbonyl]glycine
(4-fluoro-benzoylamino)-acetic acid
2-[(4-fluorophenyl)formamido]acetic acid
EN300-00196
6DD1839D93 ,
hippuric acid, p-fluoro-
glycine, n-(4-fluorobenzoyl)-
ym 385461
p-fluorohippuric acid
2-(4-fluorobenzamido)acetic acid
ym-385461
4-fluoro-hippuric acid
NVWXSGQHHUSSOU-UHFFFAOYSA-N
p-fluoro-hippuric acid
unii-6dd1839d93
3J-330S
SCHEMBL1742166
mfcd00462263
(4-fluoro-benzoylamino)-acetic acid, aldrichcpr
DTXSID30351395
4-fluorohippuric acid, analytical standard
2-(4-fluorobenzamido)aceticacid
Z56896220
(4-fluorobenzoylamino)acetic acid
4-fluorohippuric acid
Q27264564
T72371
CS-0307438
HY-W264038

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"9% (mean+/-SE, n=6) of dosage after 48h of administration."( Identification and simultaneous determination of p-FHA and p-FBA, two metabolites of anti-tumor agent--Fluorapacin in rat urine.
An, H; Jiang, H; Pan, H; Xu, X; Zeng, S; Zhou, H, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.68 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]